FDA 483 - Oxus, Inc. - September 20, 2013

An FDA inspection of Oxus America, Inc. in Rochester Hills, MI, revealed a significant issue with device master record maintenance. The firm failed to maintain an approved master specification for primary labels on its Matchbox Oxygen Concentrator medical devices. This indicates a lapse in quality system controls for device labeling.